Veranex

About

Veranex is an end-to-end, global, tech-enabled, concept-through-commercialization service provider focuses on medical technology.

Raleigh,North Carolina,United States
501 - 1000

Highlights

Details

Last Funding Type: Private Equity（PE）
Industries: Health Care,Health Diagnostics,Information Services,Medical Device
Founded date: Jan 1, 2021
Number Of Employee: 501 - 1000
Operating Status: Active
Also Known As: Veranex solutions

Veranex is the first truly end-to-end, global, tech-enabled, concept-through-commercialization service provider that focuses solely on medical technology: medical device, diagnostics, companion diagnostics, digital health, and drug delivery. For all your needs through the entire medical device clinical trial process, Veranex is transforming medtech innovations.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

—

Veranex has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Private Equity（PE） round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 18, 2022	Private Equity（PE）	—	3	—	—	Detail
Jun 16, 2021	Private Equity（PE）	—	1	Summit Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

3

Veranex is funded by 3 investors. Accelmed and Lauxera Capital Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Accelmed	—	Private Equity（PE）
Lauxera Capital Partners	—	Private Equity（PE）
Summit Partners	—	Private Equity（PE）

Employee Profiles

Number of Employee Profiles

9

Veranex has 9 current employee profiles, including Executive Luis T. Gutierrez

Executive

Executive

Executive

Executive

Executive

Acquisition

Veranex has acquired 13 organizations. Their most recent acquisition was Ximedica on Jun 16, 2021. They acquired Ximedica for 0.

Date Company Name	Industry	Acquisition Type	Price
Jun 16, 2021 Ximedica	Health Diagnostics	acquisition	—	Detail
Jun 16, 2021 Boston Healthcare	Biotechnology	acquisition	—	Detail
Jun 16, 2021 Quartesian	Education	acquisition	—	Detail
Aug 3, 2021 Experien Group	Health Care	acquisition	—	Detail
Oct 12, 2021 IMMR	Biotechnology	acquisition	—	Detail